Taipei, Taiwan

Ming-Chin Ku

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ming-Chin Ku. Retrieved from https://idiyas.com/inventor/ming-chin-ku-hrj07mf3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ming-Chin Ku

Introduction

Ming-Chin Ku is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medicine, particularly in the treatment of pleural effusion. His innovative approach combines traditional Chinese medicine with modern medical practices.

Latest Patents

Ming-Chin Ku holds a patent for a method for treating pleural effusion. This method involves administering a Chinese medicine composition to a subject in need. The composition is an extract from a first mixture, showcasing the integration of traditional remedies into contemporary medical treatments. He has 1 patent to his name.

Career Highlights

Throughout his career, Ming-Chin Ku has focused on developing effective treatment methods that bridge the gap between traditional and modern medicine. His work has garnered attention for its potential to improve patient outcomes in the treatment of pleural effusion.

Collaborations

Ming-Chin Ku has collaborated with notable colleagues, including Kun-Cheng Lin and Hsuan-Ching Tseng. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Ming-Chin Ku's innovative work in the treatment of pleural effusion exemplifies the potential of integrating traditional medicine with modern practices. His contributions continue to influence the medical field and offer new hope for patients in need.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…